TY - JOUR
T1 - The Role of Calpain in Oncotic Cell Death
AU - Liu, Xiuli
AU - Van Vleet, Terry
AU - Schnellmann, Rick G.
PY - 2004
Y1 - 2004
N2 - Numerous lines of evidence demonstrate that calpains, a family of 14 Ca2+-activated neutral cysteine proteases, are involved in oncotic cell death in a variety of models. At this time, the biochemistry of most calpains and the specific roles of different calpains in physiology and pathology remain to be determined. A number of calpain substrates have been identified in cellular systems, including cytoskeletal proteins, and recent studies suggest that calpains mediate the increase in plasma membrane permeability to ions and the progressive breakdown of the plasma membrane observed in oncosis through the proteolysis of cystokeletal and plasma membrane proteins. Further, a number of reports provide evidence that the mitochondrial dysfunction observed in oncosis may be mediated by a mitochondrial calpain of unknown identity. Finally, a number of diverse calpain inhibitors have been developed that show cytoprotective properties in cellular systems and in vivo following diverse insults. It is suggested that future research be directed toward elucidation of the role(s) of specific calpain isozymes in physiological and pathological conditions; identifying and linking specific calpain substrates with altered cellular functions; and developing cell-permeable, potent, isozyme-selective calpain inhibitors.
AB - Numerous lines of evidence demonstrate that calpains, a family of 14 Ca2+-activated neutral cysteine proteases, are involved in oncotic cell death in a variety of models. At this time, the biochemistry of most calpains and the specific roles of different calpains in physiology and pathology remain to be determined. A number of calpain substrates have been identified in cellular systems, including cytoskeletal proteins, and recent studies suggest that calpains mediate the increase in plasma membrane permeability to ions and the progressive breakdown of the plasma membrane observed in oncosis through the proteolysis of cystokeletal and plasma membrane proteins. Further, a number of reports provide evidence that the mitochondrial dysfunction observed in oncosis may be mediated by a mitochondrial calpain of unknown identity. Finally, a number of diverse calpain inhibitors have been developed that show cytoprotective properties in cellular systems and in vivo following diverse insults. It is suggested that future research be directed toward elucidation of the role(s) of specific calpain isozymes in physiological and pathological conditions; identifying and linking specific calpain substrates with altered cellular functions; and developing cell-permeable, potent, isozyme-selective calpain inhibitors.
KW - Calcium
KW - Cytoskeleton
KW - Mitochondria
KW - Oncosis
KW - Plasma membrane permeability
UR - http://www.scopus.com/inward/record.url?scp=1342281236&partnerID=8YFLogxK
U2 - 10.1146/annurev.pharmtox.44.101802.121804
DO - 10.1146/annurev.pharmtox.44.101802.121804
M3 - Review article
C2 - 14744250
AN - SCOPUS:1342281236
SN - 0362-1642
VL - 44
SP - 349
EP - 370
JO - Annual Review of Pharmacology and Toxicology
JF - Annual Review of Pharmacology and Toxicology
ER -